-
Something wrong with this record ?
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours
P. Vlasak, J. Bouda, J. Kostun, D. Berezovskiy, M. Zikan, V. Weinberger, O. Ondic, Z. Rusavy, R. Kucera, O. Topolcan, Z. Novotny, J. Presl,
Language English Country Greece
Document type Journal Article
NLK
Free Medical Journals
from 2004 to 2 years ago
Open Access Digital Library
from 2004-01-01
- MeSH
- Ascites pathology MeSH
- Cytodiagnosis MeSH
- Histocytochemistry MeSH
- Humans MeSH
- Ovarian Neoplasms diagnosis MeSH
- Punctures * methods MeSH
- Reproducibility of Results MeSH
- Retrospective Studies MeSH
- Ultrasonography * methods MeSH
- Image-Guided Biopsy * methods standards MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND/AIM: To compare the diagnostic reliability, accuracy and safety of ultrasound-guided biopsy (Tru-Cut biopsy) and ascites puncture in patients with a primarily inoperable malignant ovarian tumor. PATIENTS AND METHODS: This is a retrospective analysis of the studied methods in consecutively examined patients and a prospective validation of these methods. 79 women with a suspected primarily inoperable ovarian tumor underwent Tru-Cut biopsies and were included in the ultrasound-guided biopsy group. In addition, 55 patients after ascites puncture were enrolled in the comparison group. Both procedures were performed in 48 patients for the prospective validation. RESULTS: Significant differences in favour of ultrasound-guided biopsy were found in all studied variables (malignancy confirmation 72.9% vs. 95.8%, tumor origin 52.1% vs. 89.6%, histologic subtype 43.8% vs. 85.4% and accuracy, i.e. agreement of preoperative and definitive diagnosis 43.7% vs. 95.4%). CONCLUSION: Ultrasound-guided biopsy is an accurate, reliable, safe and minimally invasive method. Owing to the high reliability and accuracy, it has the capacity to replace ascites puncture with cytologic examination or a more invasive method (laparoscopy, laparotomy) for adequate tumor sampling.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023006
- 003
- CZ-PrNML
- 005
- 20201214125114.0
- 007
- ta
- 008
- 201125s2020 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21873/anticanres.14341 $2 doi
- 035 __
- $a (PubMed)32487654
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Vlasak, Pavel $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 245 10
- $a Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours / $c P. Vlasak, J. Bouda, J. Kostun, D. Berezovskiy, M. Zikan, V. Weinberger, O. Ondic, Z. Rusavy, R. Kucera, O. Topolcan, Z. Novotny, J. Presl,
- 520 9_
- $a BACKGROUND/AIM: To compare the diagnostic reliability, accuracy and safety of ultrasound-guided biopsy (Tru-Cut biopsy) and ascites puncture in patients with a primarily inoperable malignant ovarian tumor. PATIENTS AND METHODS: This is a retrospective analysis of the studied methods in consecutively examined patients and a prospective validation of these methods. 79 women with a suspected primarily inoperable ovarian tumor underwent Tru-Cut biopsies and were included in the ultrasound-guided biopsy group. In addition, 55 patients after ascites puncture were enrolled in the comparison group. Both procedures were performed in 48 patients for the prospective validation. RESULTS: Significant differences in favour of ultrasound-guided biopsy were found in all studied variables (malignancy confirmation 72.9% vs. 95.8%, tumor origin 52.1% vs. 89.6%, histologic subtype 43.8% vs. 85.4% and accuracy, i.e. agreement of preoperative and definitive diagnosis 43.7% vs. 95.4%). CONCLUSION: Ultrasound-guided biopsy is an accurate, reliable, safe and minimally invasive method. Owing to the high reliability and accuracy, it has the capacity to replace ascites puncture with cytologic examination or a more invasive method (laparoscopy, laparotomy) for adequate tumor sampling.
- 650 _2
- $a ascites $x patologie $7 D001201
- 650 _2
- $a cytodiagnostika $7 D003581
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a histocytochemie $7 D006651
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a ultrazvukem navigovaná biopsie $x metody $x normy $7 D061705
- 650 _2
- $a nádory vaječníků $x diagnóza $7 D010051
- 650 12
- $a punkce $x metody $7 D011677
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a ultrasonografie $x metody $7 D014463
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bouda, Jiri $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Kostun, Jan $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Berezovskiy, Denis $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Zikan, Michal $u Department of Gynecology and Obstetrics, First Faculty of Medicine and Hospital Na Bulovce, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Weinberger, Vit $u Department of Gynecology and Obstetrics, University Hospital in Brno and Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Ondic, Ondrej $u Department of Pathology, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Rusavy, Zdenek $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Kucera, Radek $u Department of Immunochemistry Diagnostics, University Hospital Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Topolcan, Ondrej $u Department of Immunochemistry Diagnostics, University Hospital Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Novotny, Zdenek $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
- 700 1_
- $a Presl, Jiri $u Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic jiri.presl77@gmail.com.
- 773 0_
- $w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 40, č. 6 (2020), s. 3527-3534
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32487654 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125113 $b ABA008
- 999 __
- $a ok $b bmc $g 1595325 $s 1113682
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 40 $c 6 $d 3527-3534 $e - $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
- LZP __
- $a Pubmed-20201125